Abstract
A number of human cancer cells become resistant to anticancer agents upon overexpression of three main membrane ATP-binding cassette (ABC) multidrug transporters, ABCB1, ABCG2 and ABCC1, of which inhibitors have been identified. Similarly, Candida albicans may become resistant to antifungals upon overexpression of the CaCrd1p ABC transporter. Structural and functional analyses of CaCdr1p indicate common features with the three human multidrug ABC transporters: same degenerescence of ATP-binding motifs as ABCC1, same “reverse” topology as ABCG2, and comparable pattern of hydrophobic, non-conjugated, substrates as ABCB1. Assaying representative inhibitors of the different human multidrug ABC transporters indicated that only those targeting ABCB1 were efficient against CaCdr1p transport activity. Potent inhibitors, able to prevent Nile Red efflux from a Saccharomyces cerevisia strain transformed to overexpress CaCdr1p and to sensitize its growth to fluconazole, were identified among macrocyclic diterpenes such as jatrophanes and lathyranes, and among other classes of compounds known to interact with ABCB1, but with different structure–activity relationships. Interestingly, other derivatives from the same series and other classes of compounds were able to inhibit CaMdr1p, a non-ABC multidrug transporter of Candida albicans, belonging to the Major Facilitator Superfamily (MFS) and overexpressed concomitantly to CaCdr1p in antifungal-resistant strains.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed-Belkacem A, Pozza A, Macalou S, Perez-Victoria JM, Boumendjel A, Di Pietro A (2006) Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2). Anticancer Drugs 17:239–243
Allen JD, van Loevezijn A, Lakhai JM, van der Valk M, van Tellingen O, Reid G, Schellens JH, Koomen GJ, Schinkel AH (2002) Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol Cancer Ther 1:417–425
Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M (1998) A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 58:5337–5339
Balzi E, Goffeau A (1995) Yeast multidrug resistance: the PDR network. J Bioeneg Biomembr 27:71–76
Boumendjel A, Macalou S, Ahmed-Belkacem A, Fortune A, Blanc M, Di Pietro A (2007) Acridone derivatives: design, synthesis and inhibition of breast cancer resistance protein ABCG2. Bioorg Med Chem 15:2892–2897
Cole SP (2014) Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present and future. Annu Rev Pharmacol Toxicol 54:95–117
Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650–1654
Conseil G, Decottignies A, Jault J-M, Comte G, Barron D, Goffeau A, Di Pietro A (2000) Prenylflavonoids as potent inhibitors of the Pdr5p multidrug ABC-transporter from Schizosaccharomyces cerevisiae. Biochemistry 39:6910–6917
Conseil G, Pérez-Victoria JM, Jault J-M, Gamarro F, Goffeau A, Hofmann J, Di Pietro A (2001) Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity. Biochemistry 40:2564–2571
Conseil G, Pérez-Victoria JM, Renoir JM, Goffeau A, Di Pietro A (2003) Potent competitive inhibition of drug binding to the Saccharomyces cerevisiae ABC exporter Pdr5p by the hydrophobic estradiol-derivative RU49953. Biochem Biophys Acta 1614:241–244
Corea G, Di Pietro A, Dumontet C, Fattorusso E, Lanzotti V (2009) Jatrophane diterpenes from Euphorbia spp. as modulators of multidrug resistance in cancer therapy. Phytochem Rev 8:431–447
Crouzet J, Trombik T, Fraysse AS, Boutry M (2006) Organization and function of the plant pleiotropic drug resistance ABC transporter family. FEBS Lett 579:6791–6795
Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95:15665–15670
Endicott JA, Ling V (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58:171–247
Gauthier C, Valdameri G, Terreux R, Kachadourian R, Day BJ, Winnischofer SMB, Rocha MEM, Frachet V, Ronot X, Di Pietro A, Boumendjel A (2012) Investigation of chalcones as selective inhibitors of the breast cancer resistance protein ABCG2: critical role of methoxy substituents in both inhibition and cytotoxicity. J Med Chem 55:3193–3200
Honorat M, Guitton J, Gauthier C, Bouard C, Lecerf-Schmidt F, Peres B, Terreux R, Gervot H, Rioufol C, Boumendjel A, Puisieux A, Di Pietro A, Payen L (2014) MBL-II-141, a chromone derivative, enhances irinotecan anticancer efficiency in ABCG2-positive xenografts. Oncotarget 5:11957–11970
Jabor Gozzi G, Bouaziz Z, Winter E, Daflon-Yunes N, Aichele D, Nacereddine A, Marminon C, Valdameri G, Zeinyeh W, Bollacke A, Guillon J, Lacoudre A, Pinaud N, Cadena SM, Jose J, Le Borgne M, Di Pietro A (2015) Converting potent indeno[1,2-b]indole inhibitors of protein kinase CK2 into selective inhibitors of the breast cancer resistance protein ABCG2. J Med Chem 58:265–277
Kaur Rawal M, Shokoohinia Y, Chianese G, Zolfaghari B, Appendino G, Taglialatela-Scafati O, Prasad R, Di Pietro A (2014) Jatrophanes from Euphorbia squamosa as potent inhibitors of Candida albicans multidrug transporter. J Nat Prod 77:2700–2706
Macalou S, Ahmed-Belkacem A, Borelli F, Capasso R, Fattorusso E, Taglialatela-Scafati O, Di Pietro A (2007) Non-prenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors. J Med Chem 50:1933–1938
Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brangi M, Greenberger L, Dean M, Fojo T, Bates SE (1999) Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res 8–24
Nakamura K, Niimi M, Niimi K, Holmes AR, Yates JE, Decottignies A, Monk BC, Goffeau A, Cannon RD (2001) Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporter. Antimicrob Agents Chemother 45:3366–3374
Niimi K, Harding DR, Parshot R, King A, Lun DJ, Decottignies A, Niimi M, Lin S, Cannon RD, Goffeau A, Monk BC (2004) Antimicrob Agents Chemother 48:1256–1271
Nim S, Monico A, Kaur Rawal M, Duarte N, Prasad R, Di Pietro A, Ferreira MJU (2016) Overcoming multidrug resistance in Candida albicans: macrocyclic diterpenes from Euphorbia species as potent inhibitors of drug-efflux pumps. Planta Med (in press)
Pasrija R, Banerjee D, Prasad R (2007) Structure and function analysis of CaMdr1p, a major facilitor superfamily antifungal efflux transporter protein of Candida albicans: identification of amino acid residues critical for drug/H+ transport. Eukaryot Cell 6:443–453
Perez-Victoria FJ, Conseil G, Munoz-Fernandez F, Perez-Victoria JM, Dayan G, Marsaud V, Castanys S, Gamarro F, Renoir JM, Di Pietro A (2003) RU49953: a non-hormonal steroid derivative that potently inhibits P-glycoprotein and reverts cellular multidrug resistance. Cell Mol Life Sci 60:526–535
Prasad R, Banerjee A, Khandelwal NK, Dhamgaye S (2015) The ABCs of Candida albicans multidrug transporter Cdr1. Eukaryot Cell 14:1154–1164
Srivalli KMR, Lakshmi PK (2012) Overview of P-glycoprotein inhibitors: a rational outlook. Braz J Pharm Sci 48:353–367
Valdameri G, Genoux-Bastide E, Peres B, Gauthier C, Guitton J, Terreux R, Winnischofer SMB, Rocha MEM, Boumendjel A, Di Pietro A (2012a) Substituted chromones as highly-potent, nontoxic inhibitors, specific for the breast cancer resistance protein ABCG2. J Med Chem 55:966–970
Valdameri G, Pereira Rangel L, Sapatafora C, Guitton J, Gauthier C, Arnaud O, Ferreira-Pereira A, Falson P, Winnischofer SMB, Rocha MEM, Tringali C, Di Pietro A (2012b) Methoxy stilbenes as potent, specific, untransported and noncytotoxic inhibitors of breast cancer resistance protein. ACS Chem Biol 7:322–330
Acknowledgements
Funding was provided by the CNRS and University of Lyon (UMR5086). The following collaborators are warmly acknowledged: R. Prasad, M. Kaur Rawal and S. Nim (Amity University Haryana, Gurgaon, India), O. Taglialatela-Scafati (University of Naples, Italy), G. Appendino (University of Novara, Italy), M-J.U. Ferreira (University of Lisbon, Portugal), M. Litaudon (CNRS-ICSN of Gif-sur-Yvette, France), E. Teodori (University of Florence, Italy), A. Boumendjel (University of Grenoble, France), M. Le Borgne (University of Lyon, France) and J. Guillon (University of Bordeaux, France). The work was initiated thanks to interesting discussions with A. Goffeau (University of Louvain-La-Neuve, Belgium) and B.C. Monk (University of Dunedin, New Zealand).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Di Pietro, A. (2017). Inhibitors of Cancer Cell Multidrug ABC Transporters: Extrapolation to Combat Candida albicans Resistance to Antifungals. In: Prasad, R. (eds) Candida albicans: Cellular and Molecular Biology. Springer, Cham. https://doi.org/10.1007/978-3-319-50409-4_24
Download citation
DOI: https://doi.org/10.1007/978-3-319-50409-4_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50408-7
Online ISBN: 978-3-319-50409-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)